Raise closed, search for fresh raises on Seedstage

Longwood, FL

Advancing dynamic tumor treating field technology to expand cancer therapy options for late-stage patients.

• Next-generation cancer treatment: Dynamic TTF delivery expands therapy to patients with multiple tumor sites.
• Experienced development team: Over 300 combined years of expertise and 60 FDA-cleared devices.
• Global patent coverage: Protected in major international markets including the U.S., EU, China, and Japan.
• Mission-driven origin: Inspired by real-world experience and focused on patient-centered innovation.
• Scalable impact: Designed to support millions of patients globally with limited treatment options.

LifeBridge Innovations is raising funds to support the continued development of its patented LB10000 device, designed to deliver a more adaptable and comprehensive version of Tumor Treating Fields (TTF) therapy. Current TTF technology, while effective for treating localized cancer, struggles to reach multiple or diffuse tumor sites due to limitations in static array placement. LifeBridge’s programmable disc system allows for dynamic field generation that can sweep across the body, ensuring more consistent treatment coverage for patients with widespread metastatic cancer. This innovation aims to make TTF therapy a viable option for late-stage cancer patients who would otherwise face limited treatment choices.

The funding will accelerate prototype testing, regulatory submission, and clinical development to eventually obtain FDA clearance. The goal is to transform metastatic cancer from a terminal condition into a manageable disease by providing an alternative treatment that has minimal side effects and improves quality of life. LifeBridge’s mission is rooted in personal experience and driven by a team with significant success in medical device development and regulatory navigation. By enabling more effective delivery of TTF, LifeBridge aims to extend the lives of patients who are no longer responding to traditional therapies and to do so in a way that remains accessible and equitable.

Company Info

LifeBridge Innovations is developing a programmable, non-invasive TTF device to treat metastatic cancer more effectively and with fewer side effects.

LifeBridge Innovations, PBC is developing a next-generation Tumor Treating Fields (TTF) device designed to treat metastatic cancer by delivering programmable electric fields that disrupt cancer cell division. The company’s patented LB10000 device uses dynamic, programmable disc arrays that overcome the limitations of existing static TTF systems, enabling treatment of widespread or diffuse cancer throughout the body. Unlike traditional cancer therapies, the LifeBridge solution is non-invasive and does not involve side effects like nausea or hair loss, making it suitable for long-term use in late-stage patients.

The founding of LifeBridge was inspired by a personal story involving a metastatic breast cancer patient who experienced extended survival and improved quality of life using early TTF prototypes developed by her husband’s team. Building on this experience, the company has secured multiple global patents, raised over $5 million, and assembled a leadership team with decades of experience and over 60 FDA-cleared devices. With TTF supported by 25 years of research, LifeBridge aims to scale access to this technology globally and reduce the terminal nature of advanced cancer by turning it into a chronic, manageable disease.